Learning Objectives:

- At the conclusion of this activity, participants will be able to understand the rationale for treatment of hemodynamically significant PDA

-- At the conclusion of this activity, participants will be able to discuss the relative benefits and risks of different medications for PDA treatment

-- At the conclusion of this activity, participants will be able to understand the concept and limitations of network meta-analyses, specifically using SUCRA values (surface under the cumulative ranking curve)

Session date: 
Thursday, October 1, 2020 - 1:30pm to 3:30pm
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Annie Wang